Q-Linea wins Premier contract position for ASTar rapid susceptibility testing system in US

• Q-linea won a contract position with Premier, giving more than 4,000 member hospitals access to pre-negotiated ASTar pricing.
• Agreement takes effect Sept. 1, 2026, covering the ASTar instrument and the ASTar BC G- kit.
• Deal is expected to shorten U.S. sales cycles by simplifying procurement, supporting faster adoption across Premier member institutions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Q-Linea AB published the original content used to generate this news brief on August 18, 2026, and is solely responsible for the information contained therein.